News EU regulator wants more advanced therapies Only a handful of products have reached the market in eight years.
Articles Mobile shift in pharma communications Balance engagement and compliance with a non-promotional, patient-centric approach and ongoing development for app success.
Pharma Market Access Accelerated Access Review: no panacea for UK pharma What can the AAR do for the UK pharma industry, the health service and patients?
Healthcare Better tasting antibiotics could reduce resistance Reformulations could help fight superbugs, says generics group
Articles NICE and Highly Specialised Technologies: three years on Leela Barham examines the process for the appraisal of Highly Specialised Technologies.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
